Kura Oncology, Inc.
Total Trades
56
Buys
2
Sells
39
Largest Trade
N/A
Insiders
11
Institutional Funds
166
Inst. Value
$1M+
Activist Filings
44
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Powl Brian T. | Chief Commercial O… | SELL | $50K–$100K | 6K | $8.46 | Jan 28, 2026 |
| FORD KATHLEEN | COO | SELL | $15K–$50K | 2K | $8.46 | Jan 28, 2026 |
| Leoni Mollie | Chief Medical Offi… | SELL | $50K–$100K | 8K | $8.46 | Jan 28, 2026 |
| DOYLE THOMAS JAMES | SVP | SELL | $50K–$100K | 7K | $8.46 | Jan 28, 2026 |
| Burrows Francis | Chief Scientific O… | SELL | $1K–$15K | 1K | $8.46 | Jan 28, 2026 |
| Bair Teresa Brophy | Chief Legal Officer | SELL | $50K–$100K | 11K | $8.46 | Jan 28, 2026 |
| Burrows Francis | Chief Scientific O… | SELL | $100K–$500K | 24K | $9.78 | Dec 19, 2025 |
| Burrows Francis | Chief Scientific O… | EXERCISE | $100K–$500K | 35K | $4.80 | Dec 19, 2025 |
| Hasnain Faheem | Director | EXERCISE | $15K–$50K | 10K | $3.12 | Dec 10, 2025 |
| Hasnain Faheem | Director | SELL | $100K–$500K | 10K | $10.98 | Dec 10, 2025 |
| Bair Teresa Brophy | Chief Legal Officer | SELL | $50K–$100K | 9K | $11.18 | Nov 15, 2025 |
| Bair Teresa Brophy | Chief Legal Officer | GRANT | N/A | 49K | — | Nov 15, 2025 |
| Powl Brian T. | Chief Commercial O… | GRANT | N/A | 49K | — | Nov 15, 2025 |
| Powl Brian T. | Chief Commercial O… | SELL | $50K–$100K | 9K | $11.18 | Nov 15, 2025 |
| Leoni Mollie | Chief Medical Offi… | SELL | $100K–$500K | 15K | $11.18 | Nov 15, 2025 |
| Leoni Mollie | Chief Medical Offi… | GRANT | N/A | 83K | — | Nov 15, 2025 |
| DOYLE THOMAS JAMES | SVP | SELL | $50K–$100K | 5K | $11.18 | Nov 15, 2025 |
| DOYLE THOMAS JAMES | SVP | GRANT | N/A | 25K | — | Nov 15, 2025 |
| FORD KATHLEEN | COO | SELL | $50K–$100K | 7K | $11.18 | Nov 15, 2025 |
| FORD KATHLEEN | COO | GRANT | N/A | 49K | — | Nov 15, 2025 |
| Powl Brian T. | Chief Commercial O… | GRANT | N/A | 49K | — | Sep 29, 2025 |
| Powl Brian T. | Chief Commercial O… | SELL | $50K–$100K | 9K | $8.94 | Sep 29, 2025 |
| Bair Teresa Brophy | Chief Legal Officer | GRANT | N/A | 49K | — | Sep 29, 2025 |
| Bair Teresa Brophy | Chief Legal Officer | SELL | $50K–$100K | 9K | $8.94 | Sep 29, 2025 |
| FORD KATHLEEN | COO | GRANT | N/A | 49K | — | Sep 29, 2025 |
| FORD KATHLEEN | COO | SELL | $50K–$100K | 7K | $8.94 | Sep 29, 2025 |
| Leoni Mollie | Chief Medical Offi… | SELL | $100K–$500K | 12K | $8.94 | Sep 29, 2025 |
| Leoni Mollie | Chief Medical Offi… | GRANT | N/A | 83K | — | Sep 29, 2025 |
| WILSON TROY EDWARD | President and CEO | GRANT | N/A | 183K | — | Sep 29, 2025 |
| WILSON TROY EDWARD | President and CEO | SELL | $100K–$500K | 37K | $8.94 | Sep 29, 2025 |
| DOYLE THOMAS JAMES | SVP | SELL | $15K–$50K | 5K | $8.94 | Sep 29, 2025 |
| DOYLE THOMAS JAMES | SVP | GRANT | N/A | 25K | — | Sep 29, 2025 |
| WILSON TROY EDWARD | President & CEO | BUY | $100K–$500K | 50K | $8.20 | Sep 9, 2025 |
| Bair Teresa Brophy | Chief Legal Officer | SELL | $1K–$15K | 2K | $5.96 | May 19, 2025 |
| FORD KATHLEEN | COO | SELL | $1K–$15K | 2K | $6.28 | May 19, 2025 |
| Hasnain Faheem | Director | SELL | $100K–$500K | 23K | $8.00 | Mar 24, 2025 |
| Hasnain Faheem | Director | EXERCISE | $100K–$500K | 23K | $6.32 | Mar 24, 2025 |
| DOYLE THOMAS JAMES | SVP | SELL | $15K–$50K | 5K | $7.87 | Jan 29, 2025 |
| Leoni Mollie | Chief Medical Offi… | SELL | $15K–$50K | 5K | $7.87 | Jan 29, 2025 |
| Bair Teresa Brophy | Chief Legal Officer | SELL | $50K–$100K | 7K | $7.87 | Jan 29, 2025 |
| FORD KATHLEEN | COO | SELL | $1K–$15K | 2K | $7.87 | Jan 29, 2025 |
| Burrows Francis | Chief Scientific O… | SELL | $15K–$50K | 2K | $7.87 | Jan 29, 2025 |
| Powl Brian T. | Chief Commercial O… | SELL | $1K–$15K | 2K | $7.87 | Jan 29, 2025 |
| FORD KATHLEEN | COO | SELL | $1K–$15K | 526 | $16.03 | Nov 19, 2024 |
| DOYLE THOMAS JAMES | SVP | SELL | $15K–$50K | 2K | $17.80 | Jan 31, 2024 |
| FORD KATHLEEN | COO | SELL | $15K–$50K | 1K | $17.80 | Jan 31, 2024 |
| Bair Teresa Brophy | Chief Legal Officer | SELL | $15K–$50K | 2K | $17.80 | Jan 31, 2024 |
| DALE STEPHEN | Chief Medical Offi… | SELL | $100K–$500K | 12K | $19.31 | Jan 31, 2024 |
| WILSON TROY EDWARD | President and CEO | EXERCISE | $500K+ | 91K | $6.05 | Jan 26, 2024 |
| WILSON TROY EDWARD | President and CEO | SELL | $1M+ | 91K | $20.23 | Jan 26, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 166 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 4.9M | $1M+ | SH |
| Prosight Management, LP | 2.5M | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.0M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.8M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $1M+ | SH |
| ALETHEA CAPITAL MANAGEMENT, LLC | 1.4M | $1M+ | SH |
| Assenagon Asset Management S.A. | 1.1M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.1M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 998K | $1M+ | SH |
| NAN FUNG TRINITY (HK) Ltd | 965K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 887K | $1M+ | SH |
| Rhenman & Partners Asset Management AB | 872K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 711K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 619K | $1M+ | SH |
| Fisher Asset Management, LLC | 472K | $1M+ | SH |
| SECTOR GAMMA AS | 456K | $1M+ | SH |
| 1492 Capital Management LLC | 453K | $1M+ | SH |
| Pale Fire Capital SE | 452K | $1M+ | SH |
| IEQ CAPITAL, LLC | 398K | $1M+ | SH |
| BARCLAYS PLC | 395K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 18, 2026
5.7%
4.9M shares
SC 13G · Feb 9, 2026
5.7%
4.9M shares
SC 13G/A · Nov 14, 2025
5.4%
4.7M shares
SC 13G/A · Nov 14, 2025
4.1%
3.3M shares
SC 13G/A · Nov 14, 2025
5.1%
4.4M shares
SC 13G/A · Aug 15, 2025
6.0%
4.7M shares
SC 13G/A · Aug 14, 2025
4.8%
4.2M shares
SC 13G/A · May 15, 2025
4.9%
4.0M shares
SC 13G/A · May 15, 2025
7.6%
6.6M shares
SUVRETTA CAPITAL MANAGEMENT, LLC
SC 13G/A · May 2, 2025
9.4%
7.6M shares
SC 13G/A · Apr 17, 2025
7.8%
6.3M shares
SC 13G · Feb 14, 2025
7.5%
5.8M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Feb 14, 2025
0.0%
0 shares
SUVRETTA CAPITAL MANAGEMENT, LLC
SC 13G/A · Feb 14, 2025
6.7%
5.2M shares
SC 13G/A · Feb 13, 2025
0.0%
0 shares
SC 13G · Feb 5, 2025
3.9%
3.0M shares
SC 13G/A · Feb 5, 2025
2.2%
1.8M shares
SC 13G · Jan 9, 2025
10.2%
7.9M shares
SC 13G · Dec 5, 2024
5.6%
4.4M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
2.8%
2.2M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
5.7%
4.3M shares
SC 13G · May 2, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
10.0%
7.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
5.1%
3.8M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2024
10.0%
7.5M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
5.4%
4.0M shares
SC 13G/A · Feb 12, 2024
7.2%
5.3M shares
SC 13G/A · Jan 24, 2024
9.8%
7.3M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
3.9%
0 shares
SC 13G · Sep 21, 2023
5.9%
4.4M shares
SC 13G/A · Feb 14, 2023
4.5%
3.1M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 13, 2023
3.0%
2.0M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2023
9.3%
6.4M shares
SC 13G/A · Feb 10, 2023
9.9%
6.6M shares
SC 13G/A · Feb 10, 2023
3.6%
2.4M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 3, 2023
6.7%
0 shares
SC 13G/A · Jan 31, 2023
7.6%
5.2M shares
Biotechnology Value Fund, L.P.
SC 13G · Dec 5, 2022
2.7%
1.8M shares
SC 13G/A · Mar 10, 2022
0.4%
241K shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 11, 2022
5.4%
3.6M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 11, 2022
5.1%
0 shares
SC 13G · Jan 31, 2022
6.8%
4.5M shares
SC 13G/A · Jan 10, 2022
8.4%
5.6M shares